Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Co-Diagnostics's operating cash flow for the twelve months ending Sep 30, 2026 was -$26.88M. For fiscal 2025 it was -$29.14M. The highest annual figure on record is $41.08M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.14M | – |
| FY2024 | Dec 31, 2024 | -$29.16M | – |
| FY2023 | Dec 31, 2023 | -$22.08M | -436.2% |
| FY2022 | Dec 31, 2022 | $6.57M | -84.0% |
| FY2021 | Dec 31, 2021 | $41.08M | +45.9% |
| FY2020 | Dec 31, 2020 | $28.17M | – |
| FY2019 | Dec 31, 2019 | -$5.53M | – |
| FY2018 | Dec 31, 2018 | -$4.08M | – |
| FY2017 | Dec 31, 2017 | -$3.21M | – |
| FY2016 | Dec 31, 2016 | -$1.31M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$5.68M | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.15M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.20M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.49M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.77M | -615.5% |
| Q2 FY2023 | Jun 30, 2023 | -$5.62M | -439.7% |
| Q1 FY2023 | Mar 31, 2023 | -$5.92M | -175.8% |
| Q4 FY2022 | Dec 31, 2022 | -$4.01M | -182.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.12M | -90.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.65M | -86.7% |
| Q1 FY2022 | Mar 31, 2022 | $7.81M | -36.4% |
| Q4 FY2021 | Dec 31, 2021 | $4.88M | -75.6% |
| Q3 FY2021 | Sep 30, 2021 | $11.51M | +34.5% |
| Q2 FY2021 | Jun 30, 2021 | $12.42M | +1158.7% |
| Q1 FY2021 | Mar 31, 2021 | $12.27M | – |
| Q4 FY2020 | Dec 31, 2020 | $19.96M | – |
| Q3 FY2020 | Sep 30, 2020 | $8.56M | – |
| Q2 FY2020 | Jun 30, 2020 | $987.07K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.34M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.61M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.22M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.33M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.37M | – |
| Q4 FY2018 | Dec 31, 2018 | -$960.64K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$967.97K | – |
| Q1 FY2018 | Mar 31, 2018 | -$968.52K | – |
| Q4 FY2017 | Dec 31, 2017 | -$992.44K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.55M | – |
| Q2 FY2017 | Jun 30, 2017 | -$247.87K | – |
| Q1 FY2017 | Mar 31, 2017 | -$419.74K | – |
| Q4 FY2016 | Dec 31, 2016 | -$555.90K | – |
See a number that looks wrong?